Original Article | Published:

Lipids and cardiovascular/metabolic health

Corn oil intake favorably impacts lipoprotein cholesterol, apolipoprotein and lipoprotein particle levels compared with extra-virgin olive oil

European Journal of Clinical Nutrition volume 71, pages 3338 (2017) | Download Citation

Abstract

Background:

Corn oil (CO) and extra-virgin olive oil (EVOO) are rich sources of unsaturated fatty acids (UFA), but UFA profiles differ among oils, which may affect lipoprotein levels.

Objectives:

The objective of this study was to assess the effects of CO versus EVOO intake on fasting lipoprotein and subfraction cholesterol levels, apolipoprotein (apo) A1, apo B, and low-density lipoprotein particle concentrations in men and women.

Subjects/Methods:

As part of a weight maintenance diet, men and women were provided with food items prepared with 54 g per day of CO or EVOO (21-day treatment, 21-day washout) in a randomized, double-blind, controlled-feeding, crossover trial. Fasting lipoprotein cholesterol and related variables were determined with density gradient ultracentrifugation.

Results:

Among the 54 completers, CO reduced total cholesterol, low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), apo B and LDL particle concentration to a greater extent compared with EVOO intake. Changes in LDL-C and VLDL-C contributed to the larger reduction in non-HDL-C with CO compared with EVOO intake (−0.39 mmol/l vs −0.04 mmol/l; P<0.001). The larger reduction in LDL-C by CO intake was attributable to changes (P<0.05) caused by CO vs EVOO in large LDL1+2-C (−0.22 mmol/l) and intermediate-density lipoprotein cholesterol (−0.12 mmol/l). HDL-C responses did not differ between treatments, but apo A1 increased more with EVOO compared with CO intake (4.6  versus 0.7 mg/dl, respectively, P=0.016).

Conclusions:

CO intake reduced atherogenic lipoprotein cholesterol and particle concentrations to a larger extent than did EVOO, which may have implications for cardiovascular disease risk.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Heart Disease Facts and Statistics.. Centers for Disease Control and Prevention2015, Available at (accessed on 19 February 2016).

  2. 2.

    , , , , , et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1–full report. J Clin Lipidol 2015; 9: 129–169.

  3. 3.

    , , , , , et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol 2015; 9: S1–S122.e1.

  4. 4.

    Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia—full report. J Clin Lipidol 2014; 8: 29–60.

  5. 5.

    , , , , , et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2960–2984.

  6. 6.

    , , , , , et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32: 1769–1818.

  7. 7.

    Department of Health and Human Services and US Department of Agriculture 2015–2020 Dietary Guidelines for Americans. 8th edn 2015, Available at .

  8. 8.

    , , , , , . Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: results from a randomized controlled feeding trial. J Clin Lipidol 2015; 9: 49–57.

  9. 9.

    , , , , , et al. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins–the Jerusalem Nutrition Study: high MUFAs vs high PUFAs. Am J Clin Nutr 1991; 53: 899–907.

  10. 10.

    , . Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992; 12: 911–919.

  11. 11.

    , , , , , et al. Analysis of cholesterol in all lipoprotein classes by single vertical ultracentrifugation of fingerstick blood and controlled-dispersion flow analysis. Clin Chem 1992; 38: 9.

  12. 12.

    , , , . Quantification of cholesterol in all lipoprotein classes by the VAP-II method. J Lipid Res 1994; 35: 159–168.

  13. 13.

    , , , , . Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women. Vasc Health Risk Manag 2012; 8: 31–38.

  14. 14.

    , . Determination of Apolipoprotein B100 by the Vertical Auto Profile Method, Birmingham, AL. Clin Chem 2007; 53.

  15. 15.

    , , . Low density lipoprotein particle concentration measurement by the Verticle Lipoprotein Profile (VLP) Method, Birmingham, AL. Natl Lipid Assoc 2014; 8: 298–299.

  16. 16.

    , , , . A novel approach to measure apolipoprotein B/apolipoprotein AI ratio using the Vertical Auto Profile method. Diab Vasc Dis Res 2007; 4: 266.

  17. 17.

    , , , , , . A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990; 51: 241–247.

  18. 18.

    , , , , , et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985; 121: 91–106.

  19. 19.

    , , . Impact of diets containing corn oil or olive/sunflower oil mixture on the human plasma and lipoprotein lipid metabolism. Eur J Nutr 2001; 40: 161–167.

  20. 20.

    , , , , . Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997; 314: 112–117.

  21. 21.

    . Polyunsaturated and monounsaturated fatty acids in the diet to prevent coronary heart disease via cholesterol reduction. Ann Nutr Metab 1994; 38: 117–122.

  22. 22.

    , , , , , et al. Effects of canola, corn, and olive oils on fasting and postprandial plasma lipoproteins in humans as part of a National Cholesterol Education Program Step 2 diet. Arterioscler Thromb 1993; 13: 1533–1542.

  23. 23.

    , , , , , et al. Dose effects of dietary phytosterols on cholesterol metabolism: a controlled feeding study. Am J Clin Nutr 2010; 91: 32–38.

  24. 24.

    US Department of Agriculture Nutrition Evidence Library. What is the effect of dietary PUFA intake on health and intermediate health outcomes? Available at accessed on 25 March 2016.

  25. 25.

    , , , , , et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ 2016; 353: i1246.

  26. 26.

    Research Review. Old data on dietary fats in context with current recommendationzs. Ask the Expert: Harvard School of Public Health, 2016, Available at accessed on 17 June 2016.

  27. 27.

    , , , , . Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia. J Clin Lipidol 2011; 5: 483–492.

  28. 28.

    , , , , , et al. Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading? Lipids Health Dis 2010; 9: 136.

  29. 29.

    , , , , , et al. Statins do not decrease small, dense low-density lipoprotein. Tex Heart Inst J 2010; 37: 421–428.

  30. 30.

    , , , , . Effects of daily almond consumption on cardiometabolic risk and abdominal adiposity in healthy adults with elevated LDL-cholesterol: a randomized controlled trial. J Am Heart Assoc 2015; 4: e000993.

  31. 31.

    , , , , . Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: a randomized, controlled trial. J Am Heart Assoc 2015; 4: e001355.

  32. 32.

    , , , . Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991; 32: 1741–1753.

  33. 33.

    , , , , . Clinical- and cost-effectiveness of LDL particle-guided statin therapy: a simulation study. Atherosclerosis 2014; 236: 154–161.

  34. 34.

    , , , , , et al. Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices. Clin Chem 2013; 59: 752–770.

  35. 35.

    , , , , , et al. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011; 217: 3–46.

  36. 36.

    , , , , , et al. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol 2011; 5: 338–367.

  37. 37.

    , , , , , et al. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement—executive summary. Endocr Pract 2013; 19: 536–557.

  38. 38.

    , , , , , et al. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial. Lipids Health Dis 2015; 14: 98.

  39. 39.

    , , , , . High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2012; 32: 2813–2820.

  40. 40.

    , . Why targeting HDL should work as a therapeutic tool, but has not. J Cardiovasc Pharmacol 2013; 62: 239–246.

  41. 41.

    Guidance for Industry. Evidence-Based Review System for the Scientific Evaluation of Health Claims-Final. US Food and Drug Administration 2009, updated 07/01/2016 Available at accessed on 26 August 2016.

  42. 42.

    , , , , , et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294: 2455–2464.

  43. 43.

    , , , . Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev 2015; 6: CD011737.

  44. 44.

    , , , , , et al. Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: a prospective cohort study. J Am Coll Cardiol 2015; 66: 1538–1548.

  45. 45.

    , , , , , et al. Impact of nonoptimal intakes of saturated, polyunsaturated, and trans fat on global burdens of coronary heart disease. J Am Heart Assoc. e-pub ahead of print 20 January 2016 doi:10.1182/blood-2013-11-539098.

Download references

Acknowledgements

We gratefully acknowledge Marjorie Huebner of Midwest Biomedical – Center for Metabolic and Cardiovascular Research for the assistance with statistical analyses.

Author information

Affiliations

  1. Midwest Biomedical – Center for Metabolic and Cardiovascular Research, Glen Ellyn, IL, USA

    • K C Maki
    • , O M Palacios
    •  & M R Dicklin
  2. Biofortis Innovation Services/Merieux NutriSciences, Addison, IL, USA

    • K C Maki
    • , A L Lawless
    • , K M Kelley
    • , V N Kaden
    •  & M R Dicklin
  3. Geiger and Associates, LLC, Fort Bridger, WY, USA

    • C J Geiger

Authors

  1. Search for K C Maki in:

  2. Search for A L Lawless in:

  3. Search for K M Kelley in:

  4. Search for V N Kaden in:

  5. Search for C J Geiger in:

  6. Search for O M Palacios in:

  7. Search for M R Dicklin in:

Competing interests

This work was funded by ACH Food Companies, Inc. (Oakbrook, IL) and PepsiCo, Inc. (Purchase, NY). Sponsor role included review and comment on study protocol and manuscript. Full editorial control remained with the investigators. The views expressed in this manuscript are those of the authors and do not necessarily reflect the position or policy of PepsiCo Inc. or ACH Food Companies, Inc.

Corresponding author

Correspondence to K C Maki.

Supplementary information

Word documents

  1. 1.

    Supplementary Table 1

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/ejcn.2016.169

Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)